Mucosal immunologic responses in cholera patients in Bangladesh

Clinical and Vaccine Immunology

Volumn 18, Issue 3, 2011, Pages 506-512

  Uddin, Taher ^a   Harris, Jason B ^b,c   Bhuiyan, Taufiqur Rahman ^a   Shirin, Tahmina ^a   Uddin, Muhammad Ikhtear ^a   Khan, Ashraful Islam ^a   Chowdhury, Fahima ^a   LaRocque, Regina C ^b,c   Alam, Nur Haque ^a   Ryan, Edward T ^b,c,d   Calderwood, Stephen B ^b,c   Qadri, Firdausi ^a  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; TOXIN ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; BANGLADESH; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM MUCOSA; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INFECTION PREVENTION; LAMINA PROPRIA; MALE; MEMORY CELL; MUCOSAL IMMUNITY; PRIORITY JOURNAL; SEROCONVERSION;

ADULT; ANTIBODIES, BACTERIAL; BANGLADESH; CHOLERA; DUODENUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MALE; TIME FACTORS; VIBRIO CHOLERAE O1;

EID: 79952562600     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00481-10     Document Type: Article

References (24)

1. Bergquist, C., A. Mattsson-Rydberg, H. Lonroth, and A. Svennerholm. 2000. Development of a new method for the determination of immune responses in the human stomach. J. Immunol. Methods 234:51-59. (Pubitemid 30084798)
2. Bhuiyan, T. R., et al. 2009. Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation. Infect. Immun. 77:1888-1893.
3. Bhuiyan, T. R., et al. 2008. Comparison of mucosal B- and T-cell responses in Helicobacter pylori-infected subjects in a developing and a developed country. FEMS Immunol. Med. Microbiol. 54:70-79.
4. Cerutti, A. 2008. The regulation of IgA class switching. Nat. Rev. Immunol. 8:421-434.
5. Darce, J. R., B. K. Arendt, S. K. Chang, and D. F. Jelinek. 2007. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J. Immunol. 178:5612-5622.
6. Fagarasan, S., S. Kawamoto, O. Kanagawa, and K. Suzuki. 2010. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu. Rev. Immunol. 28:243-273.
7. Glass, R. I., et al. 1982. Endemic cholera in rural Bangladesh, 1966-1980. Am. J. Epidemiol. 116:959-970.
8. Harris, A. M., et al. 2009. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 77:3850-3856.
9. Harris, J. B., et al. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl. Trop. Dis. 2:e221.
10. Koelle, K., M. Pascual, and M. Yunus. 2005. Pathogen adaptation to seasonal forcing and climate change. Proc. Biol. Sci. 272:971-977.
11. Levine, M. M., et al. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820.
12. high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73:523-531.
13. Nelson, E. J., J. B. Harris, J. G. Morris, Jr., S. B. Calderwood, and A. Camilli. 2009. Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat. Rev. Microbiol. 7:693-702.
14. Qadri, F., et al. 1999. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clin. Diagn. Lab. Immunol. 6:812-818.
15. Qadri, F., et al. 2003. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age. Vaccine 21:2394-2403. (Pubitemid 36564830)
16. Qadri, F., et al. 1998. Enteric infections in an endemic area induce a circulating antibody-secreting cell response with homing potentials to both mucosal and systemic tissues. J. Infect. Dis. 177:1594-1599.
17. Qadri, F., et al. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576.
18. Quiding, M., et al. 1991. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J. Clin. Invest. 88:143-148.
19. Saha, D., et al. 2004. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J. Infect. Dis. 189:2318-2322.
20. Shamsuzzaman, S., et al. 2009. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Vaccine 27:1386-1392.
21. Svennerholm, A. M., et al. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:884-893.
22. Tengvall, S., A. Lundgren, M. Quiding-Jarbrink, and A. M. Svennerholm. 2010. BAFF, stimulatory DNA and IL-15 stimulates [sic] IgA(+) memory B cells and provides [sic] a novel approach for analysis of memory responses to mucosal vaccines. Vaccine 28:5445-5450.
23. Weil, A. A., et al. 2009. Memory T-cell responses to Vibrio cholerae O1 infection. Infect. Immun. 77:5090-5096.
24. Wennerås, C., A. M. Svennerholm, C. Ahren, and C. Czerkinsky. 1992. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect. Immun. 60:2605-2611.